This was in agreement with studies that noted that EMT-TFs that regulated EMT, such as Twist, have been demonstrated to mediate the development of cancer cell resistance to platinum-based anti-cancer drugs in various cancers [33,34,35,110]. The gene discussed is TWIST1; the disease is cancer.